España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Fulcrum Therapeutics
FULC
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$6.16
0.06
0.90%
At Close: -
$6.10
-0.06
-0.89%
After Hours: Jul 2, 4:00 PM EDT
15 minutes delayed
Get Report
Watch
Fulcrum Therapeutics (FULC) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Fulcrum Therapeutics (NASDAQ:FULC) Stock
Fulcrum Therapeutics Stock (NASDAQ: FULC)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, June 11, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Monday, May 20, 2024
Cantor Fitzgerald Initiates Coverage On Fulcr...
Benzinga Newsdesk
Tuesday, May 14, 2024
Goldman Sachs Upgrades Fulcrum Therapeutics t...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Fulcrum...
Benzinga Newsdesk
Oppenheimer Maintains Outperform on Fulcrum T...
Benzinga Newsdesk
Monday, May 13, 2024
Deep Dive Into Fulcrum Therapeutics Stock: Analyst Perspectives (4 Ratings)
Benzinga Insights
Goldman Sachs Upgrades Fulcrum Therapeutics t...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Fulcrum Therapeutics shares are trading highe...
Benzinga Newsdesk
Fulcrum Therapeutics Expects Cash Balance Of ...
Benzinga Newsdesk
Fulcrum Therapeutics Q1 2024 GAAP EPS $(0.43)...
Benzinga Newsdesk
Fulcrum Therapeutics Announces License Agreem...
Benzinga Newsdesk
Wednesday, May 08, 2024
Fulcrum Therapeutics Announces Publication Of...
Benzinga Newsdesk
Friday, March 29, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Wednesday, March 13, 2024
RBC Capital Initiates Coverage On Fulcrum The...
Benzinga Newsdesk
Wednesday, March 06, 2024
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Box Reports Upbeat Earnings, Joins American Public Education, Wave Life Sciences And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Wednesday, February 28, 2024
Deep Dive Into Fulcrum Therapeutics Stock: Analyst Perspectives (4 Ratings)
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Fulcrum ...
Benzinga Newsdesk
Piper Sandler Maintains Overweight on Fulcrum...
Benzinga Newsdesk
Tuesday, February 27, 2024
Fulcrum Therapeutics Q4 GAAP EPS $(0.40) Beat...
Benzinga Newsdesk
Earnings Scheduled For February 27, 2024
Benzinga Insights
Monday, February 26, 2024
Earnings Preview: Fulcrum Therapeutics
Benzinga Insights
Friday, January 26, 2024
Goldman Sachs Maintains Neutral on Fulcrum Th...
Benzinga Newsdesk
Thursday, January 25, 2024
Goldman Sachs Maintains Neutral on Fulcrum Th...
Benzinga Newsdesk
Friday, December 22, 2023
Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Tuesday, November 07, 2023
Fulcrum Therapeutics Now Expects That Its Exi...
Benzinga Newsdesk
Fulcrum Therapeutics Q3 EPS $(0.39) Vs $(0.51...
Benzinga Newsdesk
Earnings Scheduled For November 7, 2023
Benzinga Insights
Monday, November 06, 2023
Preview: Fulcrum Therapeutics's Earnings
Benzinga Insights
Monday, September 25, 2023
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
Benzinga Insights
The Latest Analyst Ratings for Fulcrum Therapeutics
Benzinga Insights
Goldman Sachs Initiates Coverage On Fulcrum T...
Benzinga Newsdesk
Thursday, September 07, 2023
Fulcrum Announces Completion of Enrollment in...
Benzinga Newsdesk
Thursday, August 24, 2023
Why Splunk Are Trading Higher By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
Dollar Tree, Burlington Stores, Opera And Other Big Stocks Moving Lower On Thursday
Lisa Levin
Wednesday, August 23, 2023
Fulcrum Therapeutics To Rally Around 120%? FDA Update Removes Overhang On Pivotal Program
Vandana Singh
Benzinga's Top Ratings Upgrades, Downgrades For August 23, 2023
Benzinga Insights
HC Wainwright & Co. Upgrades Fulcrum Therapeu...
Benzinga Newsdesk
Tuesday, August 22, 2023
Fulcrum Therapeutics shares are trading highe...
Benzinga Newsdesk
Crude Oil Falls; Dick's Sporting Goods Earnings Miss Views
Lisa Levin
Why Macy's Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Dow Falls Over 100 Points; US Existing Home Sales Decline In July
Lisa Levin
Why Is Fulcrum Therapeutics Stock Surging Today?
Vandana Singh
Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2023
Benzinga Insights
Fulcrum Therapeutics, AMTD Digital, Hasbro And Other Big Stocks Moving Higher On Tuesday
Lisa Levin
Oppenheimer Reiterates Outperform on Fulcrum ...
Benzinga Newsdesk
US Stocks Mixed; Lowe's Posts Upbeat Earnings
Lisa Levin
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch